Korea United Pharm Inc. (KRX:033270)
South Korea · Delayed Price · Currency is KRW 18,060
-40 (-0.22%)
Jun 4, 2026, 12:34 PM KST
Korea United Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 3, 2026 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 |
| 258,645 | 213,078 | 145,180 | 133,419 | 85,273 | 95,119 | |
Market Cap Growth | -9.23% | 46.77% | 8.82% | 56.46% | -10.35% | -5.38% |
Enterprise Value | - | 209,786 | 145,115 | 133,850 | 97,148 | 107,018 |
Last Close Price | 18100.00 | 11262.00 | 7564.34 | 7137.39 | 4498.51 | 5073.98 |
PE Ratio | 14.36 | 11.60 | 11.89 | 8.15 | 4.22 | 5.58 |
Forward PE | 6.57 | 12.51 | 10.03 | - | - | - |
PS Ratio | 1.60 | 1.37 | 1.06 | 0.99 | 0.59 | 0.71 |
PB Ratio | 1.52 | 1.32 | 1.03 | 1.00 | 0.75 | 1.01 |
P/TBV Ratio | 1.56 | 1.35 | 1.04 | 1.02 | 0.77 | 1.03 |
P/FCF Ratio | 23.54 | 16.06 | 21.15 | - | 6.73 | 25.03 |
P/OCF Ratio | 10.34 | 10.00 | 7.65 | 24.22 | 3.09 | 5.58 |
EV/Sales Ratio | - | 1.35 | 1.06 | 0.99 | 0.67 | 0.79 |
EV/EBITDA Ratio | - | 7.08 | 6.91 | 5.61 | 3.10 | 4.39 |
EV/EBIT Ratio | - | 9.33 | 9.78 | 6.86 | 3.59 | 5.33 |
EV/FCF Ratio | - | 15.82 | 21.15 | - | 7.67 | 28.16 |
Debt / Equity Ratio | 0.14 | 0.15 | 0.17 | 0.17 | 0.24 | 0.27 |
Debt / EBITDA Ratio | 0.78 | 0.84 | 1.13 | 0.97 | 0.87 | 1.02 |
Debt / FCF Ratio | 2.15 | 1.87 | 3.47 | - | 2.16 | 6.57 |
Net Debt / Equity Ratio | -0.08 | -0.11 | -0.02 | -0.02 | 0.08 | 0.18 |
Net Debt / EBITDA Ratio | -0.48 | -0.61 | -0.15 | -0.12 | 0.29 | 0.70 |
Net Debt / FCF Ratio | -1.32 | -1.36 | -0.47 | 0.44 | 0.71 | 4.48 |
Asset Turnover | 0.74 | 0.76 | 0.72 | 0.75 | 0.93 | 1.01 |
Inventory Turnover | 2.64 | 2.73 | 2.36 | 2.37 | 2.97 | 3.06 |
Quick Ratio | 2.82 | 2.92 | 2.39 | 1.79 | 1.56 | 1.40 |
Current Ratio | 3.75 | 3.92 | 3.48 | 2.69 | 2.29 | 1.94 |
Return on Equity (ROE) | 12.21% | 12.19% | 8.88% | 13.28% | 19.50% | 19.74% |
Return on Assets (ROA) | 6.78% | 6.84% | 4.87% | 6.82% | 10.74% | 9.40% |
Return on Invested Capital (ROIC) | 12.08% | 12.94% | 8.66% | 12.30% | 20.61% | 17.33% |
Return on Capital Employed (ROCE) | 12.20% | 11.90% | 8.90% | 12.80% | 20.50% | 18.70% |
Earnings Yield | 7.74% | 8.62% | 8.41% | 12.28% | 23.70% | 17.93% |
FCF Yield | 4.25% | 6.22% | 4.73% | -4.98% | 14.85% | 4.00% |
Payout Ratio | 15.89% | 4.13% | 15.22% | 9.93% | 7.24% | 6.57% |
Buyback Yield / Dilution | 2.69% | 0.66% | -5.22% | -3.94% | 3.14% | 2.25% |
Total Shareholder Return | 6.06% | 0.66% | -5.22% | -3.94% | 3.14% | 2.25% |